{"id":29011,"date":"2021-01-12T12:00:00","date_gmt":"2021-01-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/"},"modified":"2021-01-12T12:00:00","modified_gmt":"2021-01-12T12:00:00","slug":"actualite-sur-icar-rs-2021","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/actualite-sur-icar-rs-2021\/","title":{"rendered":"Actualit\u00e9 sur ICAR-RS 2021"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1220 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Cette \u00e9mission est consacr\u00e9e au document de consensus international sur l\u2019allergie et la rhinologie, la rhinosinusite, ou ICAR2021. La premi\u00e8re d\u00e9claration ICAR a \u00e9t\u00e9 publi\u00e9e il y a 5 ans et, depuis, nous avons constat\u00e9 d\u2019\u00e9normes changements et progr\u00e8s dans la compr\u00e9hension et le traitement des maladies rhinologiques. Ce document contient les informations les plus compl\u00e8tes et les plus \u00e0 jour sur les causes de la rhinosinusite et sur la mani\u00e8re dont elle doit \u00eatre trait\u00e9e, sur la base de la recherche et des preuves scientifiques.  <\/p>\n<p>Le Dr Richard Orlandi, professeur d\u2019oto-rhino-laryngologie au D\u00e9partement de chirurgie de la t\u00eate et du cou de l\u2019Universit\u00e9 de l\u2019Utah (\u00c9tats-Unis), explique son enthousiasme \u00e0 propos du document ICAR2021 en raison de son caract\u00e8re exhaustif. Ce document nous aide \u00e0 comprendre l\u2019impact de la rhinosinusite et \u00e0 quel point elle affecte la qualit\u00e9 de vie dans le monde. Il existe un lien entre ICAR2021 et EPOS2020 : le document EPOS est \u00e9galement tr\u00e8s complet et rigoureux dans sa revue de la litt\u00e9rature, et les deux se compl\u00e8tent.  <\/p>\n<p>Dans le document EPOS, on s\u2019appuie davantage sur les sciences fondamentales et sur l\u2019extrapolation des connaissances dont nous disposons, en les poussant un peu plus loin pour formuler des recommandations. En examinant ICAR2021 et EPOS2020 ensemble, nous pouvons disposer d\u2019une exhaustivit\u00e9 suppl\u00e9mentaire pour aborder ces sujets. <\/p>\n<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"\/news\/latest-european-guidelines-rhinosinusitis-and-epos2020\" target=\"_blank\"><strong>Plus d\u2019informations sur EPOS2020<\/strong><\/a><\/span><\/p>\n<\/div><\/div>\n<\/p><\/div>\n<p>,  <\/p>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1221 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\">\n<center><iframe allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/LrvrzbsOWXo?rel=0\" title=\"Lecteur vid\u00e9o YouTube\" width=\"560\"><\/iframe><\/center>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cette \u00e9mission est consacr\u00e9e au document de consensus international sur l\u2019allergie et la rhinologie, la rhinosinusite, ou ICAR2021. La premi\u00e8re d\u00e9claration ICAR a \u00e9t\u00e9 publi\u00e9e il y a 5 ans et, depuis, nous avons constat\u00e9 d\u2019\u00e9normes changements et progr\u00e8s dans la compr\u00e9hension et le traitement des maladies rhinologiques. Ce document contient les informations les plus compl\u00e8tes et les plus \u00e0 jour sur les causes de la rhinosinusite et sur la mani\u00e8re dont elle doit \u00eatre trait\u00e9e, sur la base de la recherche et des preuves scientifiques. Le Dr Richard Orlandi, professeur d\u2019oto-rhino-laryngologie au D\u00e9partement de chirurgie de la t\u00eate et du cou de l\u2019Universit\u00e9 de l\u2019Utah (\u00c9tats-Unis), explique son enthousiasme \u00e0 propos du document ICAR2021 en raison de son caract\u00e8re exhaustif. Ce document nous aide \u00e0 comprendre l\u2019impact de la rhinosinusite et \u00e0 quel point elle affecte la qualit\u00e9 de vie dans le monde. Il existe un lien entre ICAR2021 et EPOS2020 : le document EPOS est \u00e9galement tr\u00e8s complet et rigoureux dans sa revue de la litt\u00e9rature, et les deux se compl\u00e8tent. Dans le document EPOS, on s\u2019appuie davantage sur les sciences fondamentales et sur l\u2019extrapolation des connaissances dont nous disposons, en les poussant un peu plus loin pour formuler des recommandations. En examinant ICAR2021 et EPOS2020 ensemble, nous pouvons disposer d\u2019une exhaustivit\u00e9 suppl\u00e9mentaire pour aborder ces sujets. Plus d\u2019informations sur EPOS2020 ,<\/p>\n","protected":false},"author":1,"featured_media":29021,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[171,297],"class_list":["post-29011","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-actualites-euforea","tag-epos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Actualit\u00e9 sur ICAR-RS 2021 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualit\u00e9 sur ICAR-RS 2021\" \/>\n<meta property=\"og:description\" content=\"Cette \u00e9mission est consacr\u00e9e au document de consensus international sur l\u2019allergie et la rhinologie, la rhinosinusite, ou ICAR2021. La premi\u00e8re d\u00e9claration ICAR a \u00e9t\u00e9 publi\u00e9e il y a 5 ans et, depuis, nous avons constat\u00e9 d\u2019\u00e9normes changements et progr\u00e8s dans la compr\u00e9hension et le traitement des maladies rhinologiques. Ce document contient les informations les plus compl\u00e8tes et les plus \u00e0 jour sur les causes de la rhinosinusite et sur la mani\u00e8re dont elle doit \u00eatre trait\u00e9e, sur la base de la recherche et des preuves scientifiques. Le Dr Richard Orlandi, professeur d\u2019oto-rhino-laryngologie au D\u00e9partement de chirurgie de la t\u00eate et du cou de l\u2019Universit\u00e9 de l\u2019Utah (\u00c9tats-Unis), explique son enthousiasme \u00e0 propos du document ICAR2021 en raison de son caract\u00e8re exhaustif. Ce document nous aide \u00e0 comprendre l\u2019impact de la rhinosinusite et \u00e0 quel point elle affecte la qualit\u00e9 de vie dans le monde. Il existe un lien entre ICAR2021 et EPOS2020 : le document EPOS est \u00e9galement tr\u00e8s complet et rigoureux dans sa revue de la litt\u00e9rature, et les deux se compl\u00e8tent. Dans le document EPOS, on s\u2019appuie davantage sur les sciences fondamentales et sur l\u2019extrapolation des connaissances dont nous disposons, en les poussant un peu plus loin pour formuler des recommandations. En examinant ICAR2021 et EPOS2020 ensemble, nous pouvons disposer d\u2019une exhaustivit\u00e9 suppl\u00e9mentaire pour aborder ces sujets. Plus d\u2019informations sur EPOS2020 ,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/\",\"name\":\"Actualit\u00e9 sur ICAR-RS 2021 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/News20Update20on20ICAR-RS20202120.png\",\"datePublished\":\"2021-01-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/News20Update20on20ICAR-RS20202120.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/News20Update20on20ICAR-RS20202120.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/actualite-sur-icar-rs-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9 sur ICAR-RS 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Actualit\u00e9 sur ICAR-RS 2021 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/","og_locale":"fr_FR","og_type":"article","og_title":"Actualit\u00e9 sur ICAR-RS 2021","og_description":"Cette \u00e9mission est consacr\u00e9e au document de consensus international sur l\u2019allergie et la rhinologie, la rhinosinusite, ou ICAR2021. La premi\u00e8re d\u00e9claration ICAR a \u00e9t\u00e9 publi\u00e9e il y a 5 ans et, depuis, nous avons constat\u00e9 d\u2019\u00e9normes changements et progr\u00e8s dans la compr\u00e9hension et le traitement des maladies rhinologiques. Ce document contient les informations les plus compl\u00e8tes et les plus \u00e0 jour sur les causes de la rhinosinusite et sur la mani\u00e8re dont elle doit \u00eatre trait\u00e9e, sur la base de la recherche et des preuves scientifiques. Le Dr Richard Orlandi, professeur d\u2019oto-rhino-laryngologie au D\u00e9partement de chirurgie de la t\u00eate et du cou de l\u2019Universit\u00e9 de l\u2019Utah (\u00c9tats-Unis), explique son enthousiasme \u00e0 propos du document ICAR2021 en raison de son caract\u00e8re exhaustif. Ce document nous aide \u00e0 comprendre l\u2019impact de la rhinosinusite et \u00e0 quel point elle affecte la qualit\u00e9 de vie dans le monde. Il existe un lien entre ICAR2021 et EPOS2020 : le document EPOS est \u00e9galement tr\u00e8s complet et rigoureux dans sa revue de la litt\u00e9rature, et les deux se compl\u00e8tent. Dans le document EPOS, on s\u2019appuie davantage sur les sciences fondamentales et sur l\u2019extrapolation des connaissances dont nous disposons, en les poussant un peu plus loin pour formuler des recommandations. En examinant ICAR2021 et EPOS2020 ensemble, nous pouvons disposer d\u2019une exhaustivit\u00e9 suppl\u00e9mentaire pour aborder ces sujets. Plus d\u2019informations sur EPOS2020 ,","og_url":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/","url":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/","name":"Actualit\u00e9 sur ICAR-RS 2021 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/News20Update20on20ICAR-RS20202120.png","datePublished":"2021-01-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/News20Update20on20ICAR-RS20202120.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/News20Update20on20ICAR-RS20202120.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/actualite-sur-icar-rs-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9 sur ICAR-RS 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/29011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=29011"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/29011\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/29021"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=29011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=29011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=29011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}